Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 241.0
(1.99%)
INR 241.0
(1.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 185.37 Million INR | 320.68% |
| 2022 | 44.06 Million INR | 486.99% |
| 2021 | 7.5 Million INR | 299.1% |
| 2020 | 1.88 Million INR | 428.31% |
| 2019 | 356.04 Thousand INR | -92.29% |
| 2018 | 4.61 Million INR | -12.12% |
| 2017 | 5.25 Million INR | 4.56% |
| 2016 | 5.02 Million INR | 321.94% |
| 2015 | 1.19 Million INR | -8.98% |
| 2014 | 1.3 Million INR | 117.04% |
| 2013 | -7.68 Million INR | 73.79% |
| 2012 | -29.3 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.85 Million INR | -89.43% |
| 2023 Q3 | 94.21 Million INR | 100.07% |
| 2023 FY | 185.37 Million INR | 320.68% |
| 2023 Q1 | 4.2 Million INR | -89.43% |
| 2023 Q2 | 47.09 Million INR | 1020.46% |
| 2023 Q4 | 39.85 Million INR | -57.69% |
| 2022 Q1 | 3.27 Million INR | -49.27% |
| 2022 FY | 44.06 Million INR | 486.99% |
| 2022 Q2 | 764 Thousand INR | -76.7% |
| 2022 Q4 | 39.76 Million INR | 15312.79% |
| 2022 Q3 | 258 Thousand INR | -66.23% |
| 2021 Q2 | 193 Thousand INR | -47.98% |
| 2021 Q4 | 6.46 Million INR | 1246.67% |
| 2021 Q3 | 480 Thousand INR | 148.7% |
| 2021 Q1 | 371 Thousand INR | 138.42% |
| 2021 FY | 7.5 Million INR | 299.1% |
| 2020 Q4 | -965.6 Thousand INR | -146.65% |
| 2020 Q1 | 187 Thousand INR | 104.63% |
| 2020 FY | 1.88 Million INR | 428.31% |
| 2020 Q2 | 922 Thousand INR | 393.05% |
| 2020 Q3 | 2.07 Million INR | 124.51% |
| 2019 Q3 | 4.21 Million INR | 1598.79% |
| 2019 FY | 356.04 Thousand INR | -92.29% |
| 2019 Q1 | 27 Thousand INR | -99.34% |
| 2019 Q4 | -4.03 Million INR | -195.77% |
| 2019 Q2 | 248 Thousand INR | 818.52% |
| 2018 FY | 4.61 Million INR | -12.12% |
| 2018 Q4 | 4.1 Million INR | 58495.69% |
| 2018 Q3 | 7000.00 INR | 102.46% |
| 2018 Q2 | -284 Thousand INR | -163.82% |
| 2018 Q1 | 445 Thousand INR | 128.86% |
| 2017 Q1 | 716 Thousand INR | -77.98% |
| 2017 Q2 | 66 Thousand INR | -90.78% |
| 2017 Q3 | 9.64 Million INR | 14507.58% |
| 2017 Q4 | -1.54 Million INR | -115.99% |
| 2017 FY | 5.25 Million INR | 4.56% |
| 2016 Q4 | 3.25 Million INR | 211.2% |
| 2016 FY | 5.02 Million INR | 321.94% |
| 2016 Q3 | 1.04 Million INR | 130.01% |
| 2016 Q2 | -3.48 Million INR | -352.5% |
| 2016 Q1 | 1.37 Million INR | 221.45% |
| 2015 FY | 1.19 Million INR | -8.98% |
| 2015 Q4 | 429 Thousand INR | 169.87% |
| 2015 Q3 | -614 Thousand INR | -167.55% |
| 2015 Q2 | 909 Thousand INR | -37.48% |
| 2015 Q1 | 1.45 Million INR | -6.08% |
| 2014 Q1 | 413 Thousand INR | -94.01% |
| 2014 Q3 | -931 Thousand INR | -290.0% |
| 2014 FY | 1.3 Million INR | 117.04% |
| 2014 Q4 | 1.54 Million INR | 266.29% |
| 2014 Q2 | 490 Thousand INR | 18.64% |
| 2013 Q3 | -3.13 Million INR | 38.25% |
| 2013 Q2 | -5.07 Million INR | 8.41% |
| 2013 Q1 | -5.54 Million INR | 76.07% |
| 2013 FY | -7.68 Million INR | 73.79% |
| 2013 Q4 | 6.88 Million INR | 319.75% |
| 2012 Q3 | 454 Thousand INR | -58.0% |
| 2012 FY | -29.3 Million INR | 0.0% |
| 2012 Q2 | 1.08 Million INR | 117.65% |
| 2012 Q1 | -6.12 Million INR | -235.25% |
| 2012 Q4 | -23.16 Million INR | -5202.71% |
| 2011 Q2 | 3.98 Million INR | 0.0% |
| 2011 Q3 | -840 Thousand INR | -121.06% |
| 2011 Q4 | 4.52 Million INR | 639.11% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 31.57 Million INR | -487.159% |
| Cian Healthcare Limited | 2.54 Million INR | -7189.501% |
| Chemo Pharma Laboratories Limited | 12 Million INR | -1444.252% |
| Colinz Laboratories Limited | 4.86 Million INR | -3708.753% |
| Denis Chem Lab Limited | 111.55 Million INR | -66.166% |
| Emmessar Biotech & Nutrition Limited | 7.49 Million INR | -2372.946% |
| Evoq Remedies Limited | 4.52 Million INR | -3997.524% |
| Gujarat Themis Biosyn Limited | 591.63 Million INR | 68.668% |
| Jenburkt Pharmaceuticals Limited | 259.77 Million INR | 28.641% |
| MedPlus Health Services Limited | 654.73 Million INR | 71.687% |
| OXYGENTA PHARMACEUTICAL LIMITE | -34.79 Million INR | 632.785% |
| PANJON LTD. | 1.51 Million INR | -12140.567% |
| PRAVEG LIMITED | 129.99 Million INR | -42.596% |
| Sanjivani Paranteral Limited. | 61.65 Million INR | -200.677% |
| Sastasundar Ventures Limited | 88.82 Million INR | -108.689% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 45758.128% |
| SHELTER PHARMA LIMITED | 62 Million INR | -198.977% |
| BDH Industries Limited | 98.67 Million INR | -87.855% |
| DECIPHER LABS LIMITED | -16.75 Million INR | 1206.302% |
| ANG Lifesciences India Limited | -101.43 Million INR | 282.757% |
| Veerhealth Care Limited | 4.06 Million INR | -4465.813% |
| Zenith Healthcare Limited | 2.03 Million INR | -9009.189% |
| Zenlabs Ethica Limited | 4.21 Million INR | -4301.045% |
| Zenotech Laboratories Limited | 82.98 Million INR | -123.375% |
| Crestchem Limited | 21.46 Million INR | -763.668% |
| Norris Medicines Limited | -11.86 Million INR | 1662.014% |
| Sunil Healthcare Limited | -17.88 Million INR | 1136.466% |
| Ambalal Sarabhai Enterprises Limited | 56.8 Million INR | -226.319% |
| Bacil Pharma Limited | -590.53 Thousand INR | 31490.785% |
| Fredun Pharmaceuticals Limited | 156.23 Million INR | -18.65% |
| Patidar Buildcon Limited | -956 Thousand INR | 19490.377% |
| Phaarmasia Limited | -5.18 Million INR | 3677.229% |
| Shree Ganesh Remedies Limited | 281.08 Million INR | 34.05% |
| SUDARSHAN PHARMA INDUSTRIES LI | 114.55 Million INR | -61.822% |
| Trimurthi Limited | 104 Thousand INR | -178142.308% |
| Vista Pharmaceuticals Limited | -45.12 Million INR | 510.842% |
| Vivanza Biosciences Limited | 5.47 Million INR | -3287.027% |
| Hindustan Bio Sciences Limited | 575.94 Thousand INR | -32085.936% |
| Anuh Pharma Limited | 600.57 Million INR | 69.134% |
| Beryl Drugs Limited | 7.68 Million INR | -2311.814% |
| Bharat Immunologicals & Biologicals Corporation Limited | -166.38 Million INR | 211.409% |
| Deccan Health Care Limited | 14.92 Million INR | -1141.94% |
| Godavari Drugs Limited | 55.48 Million INR | -234.07% |
| Gujarat Terce Laboratories Limited | 2.43 Million INR | -7515.941% |
| Ishita Drugs and Industries Limited | 7.48 Million INR | -2376.58% |
| Kerala Ayurveda Limited | -15.27 Million INR | 1313.883% |
| KIMIA BIOSCIENCES LIMITED | -53.08 Million INR | 449.185% |
| Lactose (India) Limited | 67.89 Million INR | -173.048% |
| Makers Laboratories Limited | -62.64 Million INR | 395.928% |
| Medi-Caps Limited | -22.4 Million INR | 927.258% |
| Mercury Laboratories Limited | 56.54 Million INR | -227.848% |
| Parmax Pharma Limited | -1.04 Million INR | 17912.584% |
| Roopa Industries Limited | 15.19 Million INR | -1120.275% |
| Smruthi Organics Limited | 35.9 Million INR | -416.313% |
| Source Natural Foods and Herbal Supplements Limited | 17.36 Million INR | -967.504% |
| Syschem (India) Limited | 27.61 Million INR | -571.297% |
| Vikram Thermo (India) Limited | 253.78 Million INR | 26.958% |
| Bharat Parenterals Limited | 145.17 Million INR | -27.692% |
| Trident Lifeline Limited | 63.43 Million INR | -192.205% |
| Concord Drugs Limited | 4.72 Million INR | -3824.047% |
| Gennex Laboratories Limited | 131.75 Million INR | -40.7% |
| TIAAN CONSUMER LIMITED | -23.81 Million INR | 878.547% |
| Vasundhara Rasayans Limited | 58.59 Million INR | -216.372% |
| Parnax Lab Limited | 96.09 Million INR | -92.911% |
| Trinity League India Limited | -27.07 Million INR | 784.762% |
| Sandu Pharmaceuticals Limited | 14.61 Million INR | -1168.629% |
| Tyche Industries Limited | 122.42 Million INR | -51.416% |
| Kwality Pharmaceuticals Limited | 237.96 Million INR | 22.1% |
| Transchem Limited | 42.03 Million INR | -341.005% |
| Pharmaids Pharmaceuticals Limited | -79.68 Million INR | 332.646% |
| Panchsheel Organics Limited | 141.07 Million INR | -31.399% |
| Coral Laboratories Limited | 157.89 Million INR | -17.406% |
| KOBO BIOTECH LIMITED | -49.28 Million INR | 476.1% |
| Natural Capsules Limited | 55.53 Million INR | -233.793% |
| Auro Laboratories Limited | 77.92 Million INR | -137.897% |